Table 2

AIDS-Defining Illnesses at Index Admission: Pre- and Post- Propensity Score Match


Pre-Propensity Score Match
Post-Propensity Score Match


On HAART N (%)
Not on HAART N (%)
P-value
On HAART N (%)
Not on HAART N (%)
P-value

CMV
27 (7.9)
15 (2.0)
< 0.01
27 (8.2)
8 (2.4)
< 0.01
Candidiasis
23 (6.7)
35 (4.7)
0.17
23 (7.0)
17 (5.1)
0.33
Cryptococcis
10 (2.9)
31 (4.2)
0.31
10 (3.0)
14 (4.2)
0.41
HIV Dementia
12 (3.5)
16 (2.2)
0.19
12 (3.6)
15 (4.5)
0.56
Kaposi's Sarcoma
30 (8.8)
24 (3.2)
< 0.01
30 (9.1)
17 (5.1)
0.05
Lymphoma
17 (5.0)
20 (2.7)
0.06
17 (5.1)
14 (4.2)
0.58
MAC
29 (8.5)
28 (3.8)
< 0.01
29 (8.8)
12 (3.6)
0.87
PCP
84 (24.6)
135 (18.2)
0.02
83 (25.1)
68 (20.1)
0.85
Pneumonia
29 (8.5)
83 (11.2)
0.17
29 (8.8)
30 (9.1)
0.89
Toxoplasmosis
6 (1.8)
8 (1.1)
0.36
6 (1.8)
3 (0.9)
0.78
Tuberculosis
8 (2.3)
27 (3.6)
0.26
8 (2.4)
10 (3.0)
0.79
Wasting
24 (7.0)
36 (4.9)
0.15
24 (7.3)
19 (5.7)
0.66

CMV = Cytomegalovirus, MAC = Mycobacterium Avium Complex, PCP = Pneumocystis Carinii Pneumonia.

Nosyk et al. BMC Infectious Diseases 2006 6:146   doi:10.1186/1471-2334-6-146